Boo I - Search Results

1

Calsyntenin-1 mediates hepatitis C virus replication.

Awan Z, Tay ESE, Eyre NS, Wu LE, Beard MR, Boo I, Drummer HE, George J, Douglas MW. Awan Z, et al. Among authors: boo i. J Gen Virol. 2016 Aug;97(8):1877-1887. doi: 10.1099/jgv.0.000511. Epub 2016 May 24. J Gen Virol. 2016. PMID: 27221318

2

A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.

Drummer HE, Boo I, Maerz AL, Poumbourios P. Drummer HE, et al. Among authors: boo i. J Virol. 2006 Aug;80(16):7844-53. doi: 10.1128/JVI.00029-06. J Virol. 2006. PMID: 16873241 Free PMC article.

3

Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1.

Drummer HE, Boo I, Poumbourios P. Drummer HE, et al. Among authors: boo i. J Gen Virol. 2007 Apr;88(Pt 4):1144-1148. doi: 10.1099/vir.0.82567-0. J Gen Virol. 2007. PMID: 17374757

4

A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus.

Torresi J, Stock OM, Fischer AE, Grollo L, Drummer H, Boo I, Zeng W, Earnest-Silveira L, Jackson DC. Torresi J, et al. Among authors: boo i. Hepatology. 2007 Apr;45(4):911-20. doi: 10.1002/hep.21538. Hepatology. 2007. PMID: 17393515

5

Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin.

Boo I, Fischer AE, Johnson D, Chin R, Giourouki M, Bharadwaj M, Bowden S, Torresi J, Drummer H. Boo I, et al. J Clin Virol. 2007 Aug;39(4):288-94. doi: 10.1016/j.jcv.2007.04.019. Epub 2007 Jun 14. J Clin Virol. 2007. PMID: 17569577

6

Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.

McCaffrey K, Boo I, Poumbourios P, Drummer HE. McCaffrey K, et al. Among authors: boo i. J Virol. 2007 Sep;81(17):9584-90. doi: 10.1128/JVI.02782-06. Epub 2007 Jun 20. J Virol. 2007. PMID: 17581991 Free PMC article.

7

Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.

Vietheer PT, Boo I, Drummer HE, Netter HJ. Vietheer PT, et al. Among authors: boo i. Antivir Ther. 2007;12(4):477-87. Antivir Ther. 2007. PMID: 17668556

8

The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.

McCaffrey K, Gouklani H, Boo I, Poumbourios P, Drummer HE. McCaffrey K, et al. Among authors: boo i. J Gen Virol. 2011 Jan;92(Pt 1):112-21. doi: 10.1099/vir.0.026385-0. Epub 2010 Oct 6. J Gen Virol. 2011. PMID: 20926639

9

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.

Fraser J, Boo I, Poumbourios P, Drummer HE. Fraser J, et al. Among authors: boo i. J Biol Chem. 2011 Sep 16;286(37):31984-92. doi: 10.1074/jbc.M111.269605. Epub 2011 Jul 15. J Biol Chem. 2011. PMID: 21768113 Free PMC article.

10

Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.

Boo I, teWierik K, Douam F, Lavillette D, Poumbourios P, Drummer HE. Boo I, et al. Biochem J. 2012 Apr 1;443(1):85-94. doi: 10.1042/BJ20110868. Biochem J. 2012. PMID: 22240035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters